Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder

Trial Profile

Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2013

At a glance

  • Drugs Riluzole; Serotonin uptake inhibitors; Ziprasidone
  • Indications Major depressive disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 21 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top